Pediatrix Medical Group, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B |
| Operating expenses | $1.7B | $2.1B | $2.0B | $1.8B | $1.7B |
| Operating income | $208.8M | -$68.7M | $7.3M | $172.7M | $202.9M |
| Interest expense | $36.0M | $40.7M | $42.1M | $39.7M | $68.7M |
| Pretax income | $216.4M | -$101.3M | -$48.4M | $81.4M | $135.2M |
| Income tax expense | $51.0M | -$2.3M | $12.0M | $18.8M | $27.2M |
| Net income | $165.4M | -$99.1M | -$60.4M | $66.3M | $131.0M |
| Balance Sheet | |||||
| Cash and equivalents | $375.2M | $229.9M | $73.3M | $9.8M | $387.4M |
| Current assets | $763.5M | $639.6M | $483.5M | $428.0M | $840.6M |
| Total assets | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B |
| Current liabilities | $458.9M | $434.1M | $388.9M | $427.0M | $427.4M |
| Total liabilities | $1.4B | $1.4B | $1.4B | $1.5B | $1.8B |
| Total debt | $596.9M | $615.6M | $628.1M | $644.6M | $1.0B |
| Stockholders' equity | $865.9M | $764.9M | $849.1M | $891.6M | $896.5M |
| Cash Flow Statement | |||||
| Cash from operations | $271.1M | $206.6M | $137.3M | $166.9M | $76.7M |
| Depreciation and amortization | $21.8M | $32.2M | $36.2M | $35.6M | $32.1M |
| Stock-based compensation | $18.0M | $11.9M | $12.3M | $16.1M | $19.0M |
| Capital expenditure | $18.5M | $22.0M | $33.3M | $29.7M | $32.2M |
| Free cash flow | $252.6M | $184.6M | $104.0M | $137.2M | $44.5M |
| Share repurchases | $86.7M | $1.7M | $919,000 | $88.5M | $4.7M |
| Impairments | — | $0 | $20.0M | $0 | $0 |
Shares outstanding 82.1M · Free float 94.1%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.